SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Spriet I, Meersseman W, de Hoon J, von Winckelmann S, Wilmer A, Willems L. Mini-series: II. Clinical aspects. Clinically relevant CYP450-mediated drug interactions in the ICU. Intensive Care Med 2009; 35: 60312.
  • 2
    Edelman A, Munar M, Elman MR, Koop D, Cherala G. Effect of Ethinyl estradiol/ Levonorgestrel combined oral contraceptive on the activity of Cytochrome P4503A in obese women. Br J Clin Pharmacol 2012; ‘Accepted Article’ doi: 10.1111/j.1365-2125.2012.04209.x.
  • 3
    Godfrey KM, Barker DJ. Fetal programming and adult health. Public Health Nutr 2001; 4: 61124.
  • 4
    McMillen IC, Robinson JS. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev 2005; 85: 571633.
  • 5
    Gunnarsdottir I, Birgisdottir BE, Benediktsson R, Gudnason V, Thorsdottir I. Association between size at birth, truncal fat and obesity in adult life and its contribution to blood pressure and coronary heart disease; study in a high birth weight population. Eur J Clin Nutr 2004; 58: 8128.
  • 6
    Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 2008; 359: 6173.